Asahi Ka­sei fin­ish­es $96M+ phar­ma ex­cip­i­ent man­u­fac­tur­ing plant in Japan

The Japan­ese con­glom­er­ate Asahi Ka­sei has put the fin­ish­ing touch­es on a sec­ond plant to man­u­fac­ture the phar­ma ex­cip­i­ent mi­cro­crys­talline cel­lu­lose (MCC) amid a growth …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER